Deadline for submission of applications: 20th September 2021 Background

Generating research output and encouraging young and up-and-coming  researchers is one of the pillars of Primary Care Diabetes Europe (PCDE). The  society encourages high quality research into treatment outcomes and  evaluations of new treatment options for diabetes in primary care. Working  through its research arm, the Primary Care Study Group of European  Association for the study of Diabetes (SG), PCDE aims to build a European  network of primary care researchers, with wide interests on diabetes and to  share research findings. 

Programme and Research Focus

The Study Group Research focus spans from screening through to diagnosis,  management, avoidance and treatment of complications, co-morbid  conditions, and reversal of diabetes where possible in the primary care setting.  The Programme is supported by an educational research grant from Primary  Care Diabetes Europe. 

To achieve the goals and objectives of this Programme, the SG invites  applications by issuing a call for research proposals from all of its members.  

Proposals may include but are not limited to

• Prevention of diabetes and cardiovascular diseases 

• Appropriate diagnosis of diabetes in primary care 

• Early control and avoidance of therapeutic inertia in primary care • Various treatment options. 

• Adherence and persistence 

• Treatment of diabetes complications 

• Cardio-renal-metabolic conditions 

• Addressing health inequities in diabetes 

• Diabetes and COVD-19

• Diabetes in extremes of ages 

• Epidemiology of diabetes and its complications. 

• New and advance treatment options in diabetes 

• Models of diabetes care. 

Study types can be systematic reviews and meta-analysis, service evaluations,  quality improvement projects, big data analysis, feasibility, or pilot studies. 

Support and Review Process

Research will be supported through the award of grants, each of up to Euro  10,000, although a higher grant could be considered for outstanding projects  and provided that the financial expenditure is properly documented. Half of the total budget will be paid at the beginning of the project and the second half on completion. The duration of each award may be one year to 18 month,  depending upon the needs of the project and as justified in the application.  The Study Group will support the delivery of the projects through the use of  subcommittees. These subcommittees may recommend an award in a  different amount from that requested, but which is considered more  appropriate for the proposed studies. 

The grant can also be used to support studies forming part of a larger project,  on-going or being planned, provided a good justification is provided in  application. 

Applications for SG grants are invited from study group members. We strongly encourage collaborative applications from multiple European countries.  

Applications will be subject to scientific review by 2 independent reviewers; a  specialised and independent external reviewer and the investigators suggested  reviewers.  

Prior to any final decision on funding, and to offer applicants the opportunity  to benefit from the review process, the SG reserves the right to request  revision to applications in accordance with the recommendations of the  Review Committee. 

Applications process

Applications for research grants may be subjected to pre-review (or triage)  procedures. In this event, any application rejected at pre-review will not be  subject to a complete scientific review and no feedback report will be provided  to the applicant.

The deadline for receipt of research grant applications for funding this year  is 20th of September 2021

All budgets are to be prepared in Euro. For countries in which the Euro is not  the common currency, the exchange rate (between the Euro and the local  currency in the country where they work) used for calculating the Euro budget  must be mentioned under “Budget and Costings”. 

Applications for this grant must be submitted via email to

Members of PCDE and study group members are encouraged to email their  applications to the secretariat before the deadline. 

All applications must be prepared on the official application form (see  template) in strict accordance with the detailed instructions to be found there.  Applications which do not comply with the instructions given in the application  system will not be considered for review. 

Requirements during the review process

Completed applications will be evaluated in accordance with the criteria stated  below for scientific/technical merit by an appropriate and independent  scientific committee. 

Review criteria are as follows: 

• Significance to primary care: Does the study address an important  problem in keeping with the goals and focus areas of PCDE?  • Approach: Are the conceptual framework, design, methods and analyses  adequately developed, well integrated, and appropriate to the aims of  the project?  

• Innovation: Does the project employ novel concepts, approaches or  methods? Are the aims original and innovative? Does the project  challenge existing paradigms or develop new methodologies or  technologies? 

• Investigator: Is the investigator appropriately trained and well suited to  carry out this work? Is the work proposed appropriate to the experience  level of the principal investigator and other researchers, if any? 

• Environment: Does the scientific environment in which the work will be  done contribute to the probability of success? Do the proposed studies  take advantage of unique features of the scientific environment or  employ useful collaborative arrangements? Is there evidence of  institutional support?

• Budget and feasibility: Is the requested budget appropriate for the  proposed study? Is the requested duration suitable for completion of  the project within twelve to eighteen months? 

• Contribution towards a larger research project: Is the work described in  the application intended as part of a larger project? If so, is there any  overlap? Is there a clear explanation how the new work will contribute  towards the overall success of that larger project? 

Reporting Requirements and Approval of Funding

All investigators funded by the SG are required to submit a scientific report at  the end of the project period if the manuscript has not yet been published at  the end of the project. An interim progress report will also be required. The  final manuscript or the publication must have been received prior to the  release of the final payments. 

Investigators must provide the SG with copies of papers accepted for  publication and must acknowledge the support of PCDE in all written material  by use of the phrase: ” This study was initiated and completed independently by Primary Care Diabetes Europe (PCDE). PCDE as a society, has received unrestricted corporate sponsorship from Eli Lilly and Astra Zeneca and sponsorship from Roche Diagnostics, but the companies had no input in the  study”. 


Competition opens for applications 9th August 2021 

Application Deadline 20th September 2021

Anticipated Award Date 18th October 2021